Aelis Farma

Industry · 11 registered clinical trials — 2 currently recruiting.

Status	Trial	Phase	Started
Enrolling By Invitation	Qualitative Effects of AEF0217 in Down Syndrome People Down Syndrome (Trisomy 21)	—	2026-03-01
Recruiting	AEF0217 in Participants With Down Syndrome Down Syndrome (Trisomy 21)	Phase 2	2025-12-22
Withdrawn	Drug-Drug Interaction Between THC and AEF0117 Cannabis Abuse	Phase 1	2025-12-01
Terminated	The Effect of Food on the Oral Bioavailability of AEF0117 in Healthy Volunteers Marijuana Abuse	Phase 1	2023-01-04
Completed	Study of [4-14C] AEF0117 Following a Single Oral Dose in Healthy Male Subjects Marijuana Abuse	Phase 1	2022-12-16
Completed	Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome Down Syndrome	Phase 1 / Phase 2	2022-12-15
Completed	Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD) Marijuana Abuse	Phase 2	2022-05-06
Completed	AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Heal Safety, Tolerability, Pharmacokinetics of AEF0217	Phase 1	2021-10-01
Completed	Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects Marijuana Abuse	Phase 2	2018-10-23
Completed	Multiple Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117 Healthy Volunteers	Phase 1	2018-01-08
Completed	Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117 Healthy Volunteers	Phase 1	2017-04-06